Your browser doesn't support javascript.
loading
Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation.
Meier, Franziska; Abeywardana, Tharindumala; Dhall, Abhinav; Marotta, Nicholas P; Varkey, Jobin; Langen, Ralf; Chatterjee, Champak; Pratt, Matthew R.
Afiliação
  • Meier F; Department of Chemistry, University of Southern California, Los Angeles, California 90089, United States.
J Am Chem Soc ; 134(12): 5468-71, 2012 Mar 28.
Article em En | MEDLINE | ID: mdl-22404520
ABSTRACT
The process of neurodegeneration in Parkinson's Disease is intimately associated with the aggregation of the protein α-synuclein into toxic oligomers and fibrils. Interestingly, many of these protein aggregates are found to be post-translationally modified by ubiquitin at several different lysine residues. However, the inability to generate homogeneously ubiquitin modified α-synuclein at each site has prevented the understanding of the specific biochemical consequences. We have used protein semisynthesis to generate nine site-specifically ubiquitin modified α-synuclein derivatives and have demonstrated that different ubiquitination sites have differential effects on α-synuclein aggregation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ubiquitina / Alfa-Sinucleína Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ubiquitina / Alfa-Sinucleína Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2012 Tipo de documento: Article